Clinical Trials

Revolutionary Team Award - Adaptive Response to Targeting the Androgen Axis: A Strategic Offensive on Resistance	2014 - 2019
Establishment of the Australian Prostate Cancer Research Centre – Queensland	2009 - 2019
Australian-Canadian Prostate Cancer Research Alliance	2009 - 2015

Global Action Plan 4 - INTense Exercise foR surVivAL among men with Metastatic Prostate Cancer (INTERVAL – GAP4)	2016 - 2022
Preventing the Respiratory Failure Causing COVID-19 Mortality, Potent New Drugs Targeting Hyperinflammation	2020 - 2022
Upfront PSMA Alliance	2019 - 2021
Pilot study of diagnostic accuracy of PSMA PET/MRI, mp MRI, MRI USS fusion biopsy and 'prolaris' genomic risk stratifier	2017 - 2018
A novel liver targeted therapy for sarcopaenia in androgen deprived men with prostate cancer	2016 - 2018
Precision medicine in advanced and oligometastatic prostate cancer	2016 - 2018
TrueNTH - an integrated multi-component intervention to improve the lives of men with prostate cancer in Australia	2012 - 2018
Feasibility Study - Identification of prostate cancer recurrence sites by Gallium-labelled PSMA PET/MRI in patients with biochemical recurrence following definitive therapy	2015 - 2017
ADMET Random control trial to evaluate the prognostic and metabolic benefits of metformin during androgen deprivation therapy in metastatic prostate cancer	2014 - 2017
Precision medicine in advanced prostate cancer	2015 - 2016
Evaluation of Prostate-specific Membrane Antigen Based PET and MRI for the Detection of Multiple Cancer Foci in Localised Prostate Cancer Patients	2014 - 2015
Circulating Tumour Cells Collaborative Prostate Cancer Biomarker Project	2013 - 2014